Rose Medical Center First in Colorado to Perform New Procedure for Treatment of Peripheral Arterial Disease
DENVER – Nov. 11, 2014 – Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the Lutonix ® 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.
The medication on the DCB helps prevent the tissue from scarring, slowing the additional buildup of plaque in the artery that often occurs after arterial tissue is scarred from this procedure. As a result, balloon angioplasties performed using the Lutonix ® 035 Drug Coated Balloon PTA Catheter last longer, and patients experience the benefits of this procedure for a longer period of time.
“Through the use of drug-coated balloons, we can now offer patients throughout Colorado a safe and more effective treatment for PAD,” says Dr. Sameer Mehta, director of interventional cardiology at Rose Medical Center, who performed the first procedure in Colorado. “The use of DCB can help thousands of Coloradoans who may otherwise continue to suffer from this debilitating disease.”
According to the American Heart Association® an estimated 8.5 million Americans are affected by PAD. Defined as a narrowing of the peripheral arteries, PAD restricts or blocks the flow of blood to certain areas of the body. Symptoms of patients with PAD may include cramping, pain or tiredness in the extremities. In severe cases, untreated PAD can lead to heart attack, stroke, gangrene and amputation. Most cases of PAD can be managed if diagnosed and treated properly.
“Rose is committed to bringing innovations in care to our patients, and we are excited to be the first hospital in Colorado to offer this new treatment option to our patients,” said Dr. Vijay Subbarao, medical director for the Heart & Vascular Center at Rose. “The Lutonix ® 035 DCB is a new first-line therapy for treating blockages without closing the door to other treatment options down the road, an important consideration as we help our patients manage this painful and progressive disease.”
About Rose Medical Center
Well known as a Denver institution and a 9th Avenue landmark for more than 60 years, Rose Medical Center has earned its reputation as Denver's "Baby Hospital" while becoming a leader in comprehensive women's, surgical and endoscopy services, heart and vascular, orthopedics, total joint replacement, bariatrics, and sports, internal and aesthetic medicine. With origins in Jewish teachings, traditions and community, Rose’s founders built this hospital to “serve the need of every creed.” By offering a high level of expertise and service across all disciplines, Rose has truly become a destination hospital, attracting patients from throughout Colorado and around the world. Learn more at www.rosemed.com.